Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Comment] Penile transplantation is here

Despite high initial mortality, the development of immunosuppressants has allowed solid organ transplantation to become a mainstay of modern medicine, providing a near cure for otherwise fatal conditions. Life-enhancing vascularised composite allotransplantation (VCA), such as face or hand transplantation, has increasingly been used to successfully treat devastating tissue loss. Results from a recent survey suggest that public attitudes in the USA are favourable overall towards the use of VCA, although concerns remain about seeing familiar body parts on the donor recipient, psychological discomfort, identity loss, and the need for lifelong immunosuppression to treat a non-life-threatening disease.